These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19190801)

  • 1. Using kallikrein-related peptidases (KLK) as novel cancer biomarkers.
    Schmitt M; Magdolen V
    Thromb Haemost; 2009 Feb; 101(2):222-4. PubMed ID: 19190801
    [No Abstract]   [Full Text] [Related]  

  • 2. The human kallikrein gene family: new biomarkers for ovarian cancer.
    Yousef GM; Diamandis EP
    Cancer Treat Res; 2009; 149():165-87. PubMed ID: 19763436
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
    Talieri M; Mathioudaki K; Prezas P; Alexopoulou DK; Diamandis EP; Xynopoulos D; Ardavanis A; Arnogiannaki N; Scorilas A
    Thromb Haemost; 2009 Apr; 101(4):741-7. PubMed ID: 19350120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies.
    Avgeris M; Mavridis K; Scorilas A
    Biol Chem; 2010 May; 391(5):505-11. PubMed ID: 20302518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis.
    Kountourakis P; Psyrri A; Scorilas A; Markakis S; Kowalski D; Camp RL; Diamandis EP; Dimopoulos MA
    Thromb Haemost; 2009 Mar; 101(3):541-6. PubMed ID: 19277417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human kallikrein 10, a predictive marker for breast cancer.
    Zhang Y; Bhat I; Zeng M; Jayal G; Wazer DE; Band H; Band V
    Biol Chem; 2006 Jun; 387(6):715-21. PubMed ID: 16800732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of PC3 prostate cancer cells with mitoxantrone, etoposide, doxorubicin and carboplatin induces distinct alterations in the expression of kallikreins 5 and 11.
    Thomadaki H; Mavridis K; Talieri M; Scorilas A
    Thromb Haemost; 2009 Feb; 101(2):373-80. PubMed ID: 19190824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of human kallikrein7 gene expression in colorectal cancer.
    Inoue Y; Yokobori T; Yokoe T; Toiyama Y; Miki C; Mimori K; Mori M; Kusunoki M
    Ann Surg Oncol; 2010 Nov; 17(11):3037-42. PubMed ID: 20544292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function?
    Tan OL; Whitbread AK; Clements JA; Dong Y
    Biol Chem; 2006 Jun; 387(6):697-705. PubMed ID: 16800730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human tissue kallikrein gene family: applications in cancer.
    Obiezu CV; Diamandis EP
    Cancer Lett; 2005 Jun; 224(1):1-22. PubMed ID: 15911097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression analysis and study of KLK4 in benign and malignant breast tumours.
    Papachristopoulou G; Avgeris M; Scorilas A
    Thromb Haemost; 2009 Feb; 101(2):381-7. PubMed ID: 19190825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictions for the future of kallikrein-related peptidases in molecular diagnostics.
    Scorilas A; Mavridis K
    Expert Rev Mol Diagn; 2014 Jul; 14(6):713-22. PubMed ID: 24927162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value and biological role of the kallikrein-related peptidases in human malignancies.
    Mavridis K; Scorilas A
    Future Oncol; 2010 Feb; 6(2):269-85. PubMed ID: 20146586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human tissue kallikrein gene family: a rich source of novel disease biomarkers.
    Diamandis EP; Yousef GM
    Expert Rev Mol Diagn; 2001 Jul; 1(2):182-90. PubMed ID: 11901813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there.
    Pasic MD; Olkhov E; Bapat B; Yousef GM
    Biol Chem; 2012 Apr; 393(5):319-30. PubMed ID: 22505515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicine: profile of a tumour.
    Kallioniemi O
    Nature; 2004 Mar; 428(6981):379-82. PubMed ID: 15042074
    [No Abstract]   [Full Text] [Related]  

  • 17. Tissue-specific promoter utilisation of the kallikrein-related peptidase genes, KLK5 and KLK7, and cellular localisation of the encoded proteins suggest roles in exocrine pancreatic function.
    Dong Y; Matigian N; Harvey TJ; Samaratunga H; Hooper JD; Clements JA
    Biol Chem; 2008 Feb; 389(2):99-109. PubMed ID: 18163887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembryonic antigen and cytokeratin 20 in peritoneal cells of cancer patients: are we aware of what we are detecting by mRNA examination?
    Kowalewska M; Chechlinska M; Nowak R
    Br J Cancer; 2008 Jan; 98(2):512-3; author reply 514. PubMed ID: 18195708
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer is heterogeneous.
    Guinebretiere JM
    J Clin Oncol; 2009 Jun; 27(16):2732; author reply 2734-5. PubMed ID: 19380436
    [No Abstract]   [Full Text] [Related]  

  • 20. Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers.
    Kontos CK; Scorilas A
    Clin Chem Lab Med; 2012 Nov; 50(11):1877-91. PubMed ID: 23093268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.